Market Tracker

10/24 10:42am ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

80.75
Real-Time Quote
 +5.74 / +7.65%
Today’s Change
55.04
Today|||52-Week Range
84.25
+14.78%
Year-to-Date

Today’s Trading

Previous close75.01
Today’s open75.73
Day’s range75.40 - 81.00
Volume713,528
Average volume (3 months)1,128,814
Market cap$11.0B
Dividend yield--
Data as of 10:27am ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+2.05%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book8.02

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.75+0.84%
ENDPEndo International P...-0.05-0.08%
JAZZJazz Pharmaceuticals...+2.71+1.67%
INCYIncyte Corp+0.23+0.42%
Data as of 10:39am ET, 10/24/2014

Financials

Last reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts